VRTX:Vertex Pharmaceuticals Inc Snapshot | Charting | News | Options
$423.24 NASDAQ 9:55a ET
April 10 '26 		Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producin... CNW Group
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story Top Stories on VRTX
    No News Available
    New to The Street Announces Broadcast of Show #739 on Bloomberg Telev...
    1:55p ET March 21 '26 ACCESSWIRE
    WuXi Biologics and Vertex Sign License and Research Service Agreement...
    4:06p ET March 6 '26 CNW Group
    Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chr...
    5:41p ET March 4 '26 CNW Group
    WuXi Biologics and Vertex Sign License and Research Service Agreement...
    4:39p ET March 4 '26 PR Newswire Europe
    WuXi Biologics and Vertex Sign License and Research Service Agreement...
    10:08p ET February 2 '26 PR Newswire

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2026 All rights reserved.